Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Medication adherence stories

Oct 29, 2026

Study finds one in four users discontinue insomnia drug lemborexant due to side effects

Researchers from Rutgers and other universities analyzed hundreds of online reviews of lemborexant, a prescription insomnia medication, and found that approximately 25% of reviewers stopped or planned to stop taking the drug due to troubling side effects.

Oct 29, 2026·2 sources
00
Oct 28, 2026

WHO releases target regimen profiles for long-acting injectable tuberculosis treatments

The World Health Organization has published target regimen profiles for long-acting injectables (LAIs) for tuberculosis prevention and treatment, aiming to address adherence challenges associated with current daily oral regimens that must be taken over months.

Oct 28, 2026·1 source
00
Oct 27, 2026

Study finds long-acting cabotegravir and rilpivirine maintains HIV viral suppression

Research presented at IDWeek shows that long-acting injectable antiretroviral therapy combining cabotegravir and rilpivirine consistently maintains virologic suppression in adults with HIV who were previously virologically suppressed. The real-world study addresses questions about the effectiveness of switching from oral to injectable ART.

Oct 27, 2026·2 sources
00
Aug 5, 2026

Study finds diabetes drug tirzepatide reduces heart attack and stroke risk in high-risk patients

New research published in The BMJ shows that tirzepatide (Mounjaro), a GLP-1 receptor agonist, reduces the risk of major cardiovascular events by 33% in type 2 diabetes patients with existing heart disease. A separate study also found that consistent medication adherence among diabetes patients reduces heart disease risk by 27%.

Aug 5, 2026·11 sources
00

Study finds diabetes drug tirzepatide reduces heart attack and stroke risk in high-risk patients

New research published in The BMJ shows that tirzepatide (Mounjaro), a GLP-1 receptor agonist, reduces the risk of major cardiovascular events by 33% in type 2 diabetes patients with existing heart disease. A separate study also found that consistent medication adherence among diabetes patients reduces heart disease risk by 27%.

Aug 5, 2026·9 sources
00
Apr 9, 2026

Study Links $35 Insulin Cap to Improved Treatment Adherence in Type 2 Diabetes

Research demonstrates that capping insulin costs at $35 per month significantly improves medication adherence among patients with type 2 diabetes, providing evidence for price control policies.

Apr 9, 2026·1 source
00

Top claims

  • ▪Nearly one-third of online reviewers analyzing lemborexant described experiencing vivid dreams or nightmares while taking the insomnia drug.
  • ▪A study by researchers from Rutgers, Virginia Commonwealth University, and the University of Sydney found that 70 out of 260 online reviewers (about 1 in 4) stopped or planned to stop taking the insomnia drug lemborexant.
  • ▪Study lead author Abanoub J. Armanious stated that clinical trials track side effect frequency but are less equipped to measure how much a side effect impacts a patient's decision to discontinue treatment.

Subtopics

Cardiovascular health.2Drug Approval and Clinical Trials2Drug Policy, Pricing & Approval2GLP-1 medications2Injectable drug delivery devices2Antiviral therapy1Biomarkers & bloodwork testing1Blood sugar & insulin1Chronic disease management1Clinical trials1Drug Classes & Treatment Access1Drug development1Drug safety1Global health1GLP-1 / Weight-Loss Medications1Infectious Disease and Outbreaks1Insomnia1Intramuscular (depot)1Medication Management & Adherence1Metabolic health1Observational research1Patient experience1Preventive medicine1Public health policy1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories